John Ransom
Stock Analyst at Raymond James
(4.51)
# 294
Out of 4,711 analysts
226
Total ratings
63.82%
Success rate
14.47%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $303.62 | - | 21 | Nov 22, 2024 | |
| THC Tenet Healthcare | Downgrades: Outperform | $195 | $129.46 | +50.63% | 17 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $3.16 | - | 8 | Nov 22, 2024 | |
| SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $81.61 | +4.15% | 12 | Nov 1, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.44 | +125.23% | 2 | May 16, 2024 | |
| RDNT RadNet | Maintains: Outperform | $50 → $60 | $72.70 | -17.47% | 10 | May 10, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $94.45 | +0.58% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $9.55 | - | 7 | Mar 26, 2024 | |
| AMED Amedisys | Maintains: Market Perform | n/a | $84.47 | - | 14 | Mar 26, 2024 | |
| HUM Humana | Initiates: Market Perform | n/a | $247.10 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.09 | +41.94% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $25.16 | +19.24% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $16 | $3.48 | +359.77% | 3 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $10.61 | +13.10% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $310 → $330 | $276.92 | +19.17% | 16 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $44.36 | +91.61% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $131.40 | -20.09% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $5.35 | +86.92% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.58 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.09 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.76 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $630 | $500.13 | +25.97% | 12 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $37.90 | +163.85% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $50.73 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $31.45 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $151.85 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.22 | - | 2 | Aug 9, 2017 |
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $303.62
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $129.46
Upside: +50.63%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.16
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $81.61
Upside: +4.15%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.44
Upside: +125.23%
RadNet
May 10, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $72.70
Upside: -17.47%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $94.45
Upside: +0.58%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $9.55
Upside: -
Amedisys
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $84.47
Upside: -
Humana
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $247.10
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $14.09
Upside: +41.94%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $25.16
Upside: +19.24%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $16
Current: $3.48
Upside: +359.77%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $10.61
Upside: +13.10%
Aug 7, 2023
Maintains: Strong Buy
Price Target: $310 → $330
Current: $276.92
Upside: +19.17%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $44.36
Upside: +91.61%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $131.40
Upside: -20.09%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $5.35
Upside: +86.92%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.58
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.09
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.76
Upside: -
Apr 17, 2023
Maintains: Strong Buy
Price Target: $630
Current: $500.13
Upside: +25.97%
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $37.90
Upside: +163.85%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $50.73
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $31.45
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $151.85
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.22
Upside: -